Results 251 to 260 of about 44,698 (310)

The erythropoietin gene polymorphism (rs1617640) is associated with retinopathy in type 2 diabetes patients. [PDF]

Acta Diabetol
Szeliga-Krol J, Betlejewska A, Buraczynska M, Zaluska W.   +3 more
europepmc   +1 more source

Fronting in Old Catalan: Asymmetries between Narration and Reported Speech1

Transactions of the Philological Society, Volume 123, Issue 1, Page 1-28, March 2025.
Abstract This article explores the distribution, syntax, and information structure of XVS clauses in the narrative text and the reported speech of a thirteenth‐century Old Catalan chronicle, the Llibre dels Fets. It is shown that XVS occurs mainly within reported speech and in embedded clauses.
Afra Pujol i Campeny
wiley   +1 more source

Erythropoietin exposure disrupts B cell development and drives the emergence of myeloid-biased biphenotypic progenitors. [PDF]

Stem Cell Reports
Chiron-Margerie A, Bessoles S, Sarrabayrouse G, Alhaj-Hussen K, Joulain C, Darde T, de la Grange P, Abina AM, Canque B, Krzysiek R, Hacein-Bey-Abina S.   +10 more
europepmc   +1 more source

A Literature Review of Underlying Molecular Factors Contributing to the Pathogenesis of Diabetic Eye Disease. [PDF]

Cureus
Inamdar N, Deshpande M.
europepmc   +1 more source

Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera. [PDF]

Commun Med (Lond)
Li X, An W, Wang X, Yin Z, Gao Y, Lan Y, Zhang L, Zhao B, Chang L, Ruan M, Zhang L, Zou Y, Yang W, Zhu X.   +13 more
europepmc   +1 more source

Relief with a catch: hemodilution in chronic mountain sickness sparks an erythropoietin surge. [PDF]

Blood Red Cells Iron
Villafuerte FC, Swietach P.
europepmc   +1 more source

Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline Mutation. [PDF]

Am J Hematol
Lanikova L, Hrckulak D, Zimolova V, Lorenzo FR, Song J, Vecerkova K, Babosova O, Berkova L, Korinek V, Elliott S, Prchal JT.   +10 more
europepmc   +1 more source

Comparison the clinical outcomes of intravenous and subcutaneous erythropoietin administration in hemodialysis patients of plateau regions. [PDF]

BMC Nephrol
Li Y, Yang C, Xu J, Li D, Xu M, Zhou Z.
europepmc   +1 more source

Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients

Kidney International, 2005
Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients.BackgroundSince 1998, an increase of anti-erythropoietin (anti-EPO) antibody-induced pure red cell aplasia (PRCA) has ...
Jan P Vandenbroucke, Elisabeth W Boeschoten, Raymond T Krediet   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

EPO or Not-EPO? An Evidence Based Informed Consent

The International Journal of Artificial Organs, 2004
Background Informed consent is crucial in therapeutic choices; however, the forms presented to patients are often locally developed and information may not be homogeneous. Objective To prepare an evidence-based model for informed ...
E, Mezza, G B, Piccoli, A, Pacitti, G, Soragna, F, Bermond, M, Burdese, M, Gai, D, Motta, A, Jeantet, F, Merletti, P, Vineis, G P, Segoloni   +11 more
openaire   +2 more sources